|
Post by parrerob on Jul 6, 2024 5:16:23 GMT -5
|
|
|
Post by Clement on Jul 6, 2024 6:12:04 GMT -5
That's for the clofazimine trial in Japan.
|
|
|
Post by parrerob on Jul 6, 2024 6:24:44 GMT -5
Right.... Now I remember... communicated during last earning call
|
|
|
Post by prcgorman2 on Jul 6, 2024 11:39:40 GMT -5
Nice to see action confirming the words. It will be good if clofazimine becomes another good revenue source like Tyvaso DPI fueling MannKind pipeline and marketing.
|
|